Global Fund general manager appeals for donations, calling fund a 'good deal'

Gabriel Jaramillo, general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, "took a new approach to appealing for donations last week, arguing to finance ministers from participating nations that the fund is a great investment," the New York Times reports. Calling investment in the fund "a good deal," Jaramillo, a former banker, "urged ministers meeting in Tunisia to 'put your skin in the game now, because the out-years will be much cheaper as your number of cases goes down,'" the newspaper writes. As an example of "cost-efficiency," he cited Namibia, which spends $120 million annually on HIV treatment -- half of which comes from the Global Fund -- and has seen a drop from 2,700 AIDS-related deaths per year to 56 per year over five years, according to the newspaper (McNeil, 7/9).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Maternal antibodies may hinder malaria vaccine effectiveness in infants